)
)
)
Couragene, Inc.
Couragene is a pre-clinical stage biotechnology company developing first-in-class, non-viral delivery platforms that enable highly efficient, brain-wide delivery of genetic medicines. Its lead pre-IND program focuses on a genome-editing therapy for Angelman syndrome (AS), with efficacy and biodistribution already validated in non-human primates (NHPs).
Address
North BrunswickNew Jersey
United States
)
){kind=logo}
)
){kind=logo}
){kind=logo}
)
)
)
)